Protein aggregation is a major factor limiting the biotechnological and therapeutic application of many proteins, including enzymes and monoclonal antibodies. The molecular principles underlying aggregation are complex and multifaceted, involving various interactions between proteins, ions, and other molecules. Understanding these mechanisms is crucial for developing effective therapeutic strategies to prevent or mitigate protein aggregation, thereby improving the quality of life for individuals affected by these diseases.